PureTech Health FY 2023 GAAP EPS $(0.24) Beats $(0.93) Estimate, Sales $3.330M Down From $15.618M YoY
PureTech Health FY 2023 GAAP EPS $(0.24) Beats $(0.93) Estimate, Sales $3.330M Down From $15.618M YoY
PureTech Health 2023财年GAAP每股收益美元（0.24美元）超过预期（0.93美元），销售额为333万美元，低于同比156.18亿美元
PureTech Health (NASDAQ:PRTC) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.93) by 74.19 percent. The company reported $3.330 million in sales this quarter. This is a 78.68 percent decrease over sales of $15.618 million the same period last year.
PureTech Health（纳斯达克股票代码：PRTC）公布的季度亏损为每股0.24美元，比分析师普遍预期的0.93美元（0.93美元）高出74.19％。该公司报告本季度销售额为3330万美元。这比去年同期的1561.8万美元的销售额下降了78.68％。